Mika Kamata-Sakurai, Ph.D.Senior Director, Translational Research Division at Chugai Pharmaceutical Co., Ltd.
Mika Kamata-Sakurai, Ph.D. is a senior director at Chugai Pharmaceutical Co., Ltd., in Japan. She has more than 10 years of experience in the pharmaceutical industry and has led multiple projects in oncology. During her career, Dr. Kamata-Sakurai has held positions in both academia and industry, focusing on the development, application, and testing of cancer vaccines, therapeutic antibodies, protein libraries, protein evolution technologies, engineered antibodies, and novel biologics. She received her Ph.D. from the University of Tokyo for her thesis on cancer immunotherapy. She is skilled in genetic engineering, molecular biology, biochemistry, and pharmacology, especially as they relate to oncology.